Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Gains from Investment Securities (2020 - 2025)

Doximity (DOCS) has disclosed Gains from Investment Securities for 6 consecutive years, with -$295000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 28.22% to -$295000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $108000.0, a 108.67% increase, with the full-year FY2024 number at -$2.6 million, down 167.58% from a year prior.
  • Gains from Investment Securities was -$295000.0 for Q4 2025 at Doximity, up from -$11.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $27.5 million in Q3 2023 to a low of -$31.1 million in Q4 2023.
  • A 5-year average of $14050.0 and a median of $70500.0 in 2021 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 18212.5% in 2022; the steepest drop was 1328.32% in 2022.
  • Doximity's Gains from Investment Securities stood at $1.0 million in 2021, then plummeted by 1328.32% to -$12.4 million in 2022, then plummeted by 150.4% to -$31.1 million in 2023, then skyrocketed by 98.68% to -$411000.0 in 2024, then rose by 28.22% to -$295000.0 in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Gains from Investment Securities are -$295000.0 (Q4 2025), -$11.8 million (Q3 2025), and $11.9 million (Q2 2025).